Pfizer, Development Organizations To Expand Injectable Contraceptive Access In Developing Countries
News outlets report on an announcement that the pharmaceutical company Pfizer, in collaboration with development organizations, will expand access to its injectable contraceptive for women in developing countries.
New York Times: Pfizer and Aid Groups Team Up on Depo-Provera Contraceptive for Developing World
“Depo-Provera, an injectable contraceptive given once every three months, is already a popular choice of women in developing countries, who value the convenience and discretion of not having to take a daily birth control pill. But the injections are out of reach for many more women because they live in rural areas that are too far from a health clinic to make the treatments practical. Now, a major collaboration between Pfizer, the drug’s manufacturer, and several global aid groups is aiming to change that by providing financing to make a new version of the drug — redesigned with developing countries in mind — available in 69 nations throughout Africa, Asia, Latin America, and Eastern Europe…” (Thomas, 11/13).
Reuters: Pfizer, Gates Foundation, expand contraceptive access in poor nations
“Pfizer Inc. and the Bill & Melinda Gates Foundation on Thursday announced an agreement to expand access to the drugmaker’s long-acting Sayana Press contraceptive to women in 69 of the world’s poorest countries, for $1 per dose…” (Pierson, 11/13).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.